Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium
Recruiting
Phase 4
Interventional Study
Emergence Delirium
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 2 – 6
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 50 (estimated)
- Sponsor
- Kasr El Aini Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups. Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Scheduled for elective cardiac catheterization under general anesthesia.
Exclusion Criteria:
* neurological disorder, psychiatric disease, or current psychoactive medication.
* allergy.
* significant systemic comorbidities.
Contacts